SS
SADHANA SATHAYE
Institute of Chemical Technology, NSS College of Pharmacy, Mumbai, Grant Medical College and Sir JJ Group of Hospitals
Employment
-
Institute of Chemical Technology Professor2009 - Present
-
Institute of Chemical Technology Associate Professor2006 - 2009
-
Institute of Chemical Technology Selection in Pharmacy2003 - 2006
-
Institute of Chemical Technology Senior Lecturer in Pharmacy1998 - 2003
-
NSS College of Pharmacy, Mumbai Lecturer in Pharmacology1991 - 1998
Education
-
Institute of Chemical Technology PhD1999 - 2006
-
Grant Medical College and Sir JJ Group of Hospitals Master of Pharmacy1983 - 1986
-
Institute of Chemical Technology Bachelor of Pharmacy1980 - 1983
Projects & Funding
Projects & funding information is unavailable.
Publications (11)
- UV‐Spectrophotometric and RP‐HPLC Method Development and Validation for Simultaneous Estimation of Gallic Acid, Quercetin, Luteolin, and Apigenin in Saraca asoca Extract Save
- Formulation development and preclinical assessment of ethyl acetate fraction of Saraca asoca (EASA) flowers for cataract management Save
- Exploring the therapeutic utility of apocynin in multifactorial neurodegenerative Alzheimer’s disease in a preclinical animal model Save
- Soy isoflavone Daidzein resembling the vertebrate steroid structure exhibits neuroprotection via mitochondrial biogenesis in rotenone induced Parkinson’s disease in preclinical model Save
- Exploring berberine’s therapeutic network: a pharmacological approach to kidney disease Save
- Synthesis, in silico studies and in vitro evaluation of benzimidazole and benzotriazole derivatives as efflux pump inhibitors Save
- Indoleamine-2,3-Dioxygenase 1 Enzyme Inhibition: a Useful Target to Screen Chemicals for their Therapeutic Potential Save
- Uncovering the Significance of STEP61 in Alzheimer’s Disease: Structure, Substrates, and Interactome Save
- Evaluation of Benzamide-Chalcone Derivatives as EGFR/CDK2 Inhibitor: Synthesis, In-Vitro Inhibition, and Molecular Modeling Studies Save
- Ethyl ferulate, a lipophilic phenylpropanoid, prevents diabetes‐associated renal injury in rats by amelioration of hyperglycemia‐induced oxidative stress via activation of nuclear factor erythroid 2‐related factor 2 Save